Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Allergan has received a subpoena from the US Attorney's Office for the Northern District of Georgia requesting the production of documents regarding promotional practices involving Botox for therapeutic indications.
Subscribe to our email newsletter
The subpoena broadly requests documents regarding promotional, educational and other activities relating to Botox. The company’s current understanding is that the inquiry involves questions regarding alleged off label promotion relating to the use of Botox for the treatment of headache.
Allergan has said that it will fully cooperate with the US Department of Justice to satisfactorily address any and all of their questions regarding this matter.